Form 4: LeMaitre CEO Reports Routine Stock Transactions

LeMaitre Vascular Inc.'s Chairman and CEO, George W. LeMaitre, reported routine beneficial ownership changes related to equity award vesting and tax withholding.

Summary

• George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc. (LMAT), reported changes in his beneficial ownership of common stock.
• On December 8, 2025, Mr. LeMaitre acquired 21 shares and 25 shares of common stock upon the release of dividend equivalent rights, associated with the vesting of restricted stock units (RSUs) and performance stock units (PSUs) granted on December 8, 2023.
• Concurrently, 567 shares were disposed of to satisfy tax withholding obligations related to the vesting of RSUs, at a price of $82.93 per share.
• An additional 681 shares were disposed of for tax withholding obligations incurred upon the vesting of PSUs, also at $82.93 per share.
• Following these transactions, Mr. LeMaitre directly owns 1,663,830 shares of common stock.
• He also indirectly owns 21,300 shares through the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to equity compensation vesting and tax withholding, which are standard and expected events, thus indicating a neutral sentiment.

Positives

• Vesting of restricted stock units and performance stock units indicates the executive met performance or time-based criteria.
• Acquisition of 46 shares (21+25) through dividend equivalent rights.

Negatives

• Disposal of 1,248 shares (567+681) to cover tax withholding obligations, resulting in a net decrease in direct beneficial ownership from the transactions.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions related to equity compensation, which is a common practice across all industries for executive remuneration and retention. It does not provide information on broader industry trends or competitive landscape.

Related Party Transactions

• The filing discloses indirect beneficial ownership of 21,300 shares held by the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025, which is for the benefit of the Reporting Person's child(ren). The Reporting Person disclaims ownership except for pecuniary interest.

Stakeholder Impact

• Shareholders: Minimal impact as these are routine insider transactions related to compensation, not a discretionary sale or purchase indicating a change in management's view of the company.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

The Form 4 filing details routine insider transactions involving the vesting of equity awards and subsequent share disposals for tax withholding. These are standard compensation events and do not reflect a discretionary investment decision by the insider that would typically signal a change in the company's fundamental outlook or warrant a shift in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing provides no new information to alter an existing investment thesis.

Keywords

LeMaitre Vascular, LMAT, Insider Transaction, Form 4, Beneficial Ownership, CEO Stock, Equity Compensation, Restricted Stock Units, Performance Stock Units, Tax Withholding